Scientists have discovered a nanocolloid contrasting agent for MRIs that is safer than gadolinium. The new agent does not pose the same risk of developing tissue disorders that gadolinium does.

The agent was formed by stirring manganese oxide nanoparticles in a mixture of vegetable oil and surfactant to give the nanoparticle phospholipid shells. These nanocolloids work well as contrast agents because of their sensitivity to fibrin, a major component of blood clots. The agent can also be easily metabolized and excreted by the body, making it safe for use.

If you or someone you know has been treated with gadolinium, contact the NSF lawyers of Williams Kherkher at 800-761-3187.